| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 136 |
| 1 | ADALIMUMAB | 135 |
| 2 | FOLIC ACID | 134 |
| 3 | TOCILIZUMAB | 131 |
| 4 | ABATACEPT | 129 |
| 5 | LEFLUNOMIDE | 123 |
| 6 | METHOTREXATE SODIUM | 123 |
| 7 | TOFACITINIB | 116 |
| 8 | METHOTREXATE | 114 |
| 9 | NAPROXEN SODIUM | 103 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAPROXEN SODIUM 220MG | 67 | 0.0049 |
| 1 | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | 1 | 0.0030 |
| 2 | VALPROATE SODIUM | 53 | 0.0025 |
| 3 | ACETAMINOPHEN AND CODEINE | 17 | 0.0014 |
| 4 | LEFLUNOMIDE | 123 | 0.0012 |
| 5 | TOCILIZUMAB | 131 | 0.0011 |
| 6 | GOLIMUMAB | 14 | 0.0011 |
| 7 | HYDROXYCHLOROQUINE SULFATE | 98 | 0.0011 |
| 8 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 3 | 0.0010 |
| 9 | HUMAN RHO(D) IMMUNE GLOBULIN | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 137 |
| 1 | Vitamin C [EPC] | 136 |
| 2 | Vitamin B12 [EPC] | 135 |
| 3 | Vitamin D [EPC] | 135 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 131 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 129 |
| 6 | Antirheumatic Agent [EPC] | 123 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 114 |
| 8 | Corticosteroid [EPC] | 100 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 100 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antirheumatic Agent [EPC] | 123 | 0.0012 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 131 | 0.0009 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 129 | 0.0009 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Vitamin D [EPC] | 135 | 0.0004 |
| 5 | Vitamin B12 [EPC] | 135 | 0.0004 |
| 6 | Interleukin-17A Antagonist [EPC] | 15 | 0.0004 |
| 7 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 8 | Vitamin C [EPC] | 136 | 0.0003 |
| 9 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 3 | 0.0003 |